Protox Therapeutics Inc., of Vancouver, British Columbia, named William Rohn and Arnit Sobti to its board...Tranzyme Pharma Inc., of Research Triangle Park, N.C., appointed Anne M. VanLent to its board

AspenBio Pharma Inc., of Castle Rock, Colo., added Erik S. Miller as vice president of marketing and business development

and Manuela Maronati vice president, sales and marketing, Europe...Laureate Pharma Inc., of Princeton, N.J., appointed Kathleen P. Bloch chief financial officer

Acceleron Pharma Inc., of Cambridge, Mass., named Kevin F. McLaughlin senior vice president and chief financial officer

Regenicin Inc., of New York, added Joseph Rubinfeld and Craig Eagle to its board...Scolr Pharma Inc., of Bothell, Wash., appointed Carl Johnson chairman

Kite Pharma Inc., of Los Angeles, appointed Aya Jakobovits president and CEO...Laureate Pharma Inc., of Princeton, N.J., appointed Steven R. Johnson vice president of business development

BioMarin Pharmaceutical Inc., of Novato, Calif., appointed William D. Young and Kenneth M. Bate to its board...EUSA Pharma Inc., of Oxford, UK, appointed Stephen A. Stamp to its board

ATyr Pharma Inc., of San Diego, named Catharine E. Johnson senior vice president of business development...and Jonathan M. Spergel to its scientific advisory board

Cerulean Pharma Inc., of Cambridge, Mass., appointed John Ryan senior vice president and chief medical officer and named Karen Roberts senior vice president of finance and administration

AspenBio Pharma Inc., of Castle Rock, Colo., has appointed Steve Lundy CEO and a member of its board

Aton Pharma inc., of Lawrenceville, N.J., named Michael H. Richardson vice president of commercial operations for the orphan drug business unit and appointed Donald A. Fishbein vice president of commercial operations for the ophthalmic business unit

Laureate Pharma Inc., of Princeton, N.J., named Andrew Arrage and Patricia Caplan directors of business development, East, and appointed Bruce Frazier manager of business development, West

NeuroTherapeutics Pharma Inc., of Chicago, appointed Corey S. Goodman to its board...XOMA Ltd., of Berkeley, Calif., appointed Susan Kramer vice president, project and alliance management

AspenBio Pharma Inc., of Castle Rock, Colo., added Andrew Peters as vice president of animal health and named Mary Nunnally vice president of quality management

AspenBio Pharma Inc., of Castle Rock, Colo., named Gregory L. Bennett vice president of product development and manufacturing

Laureate Pharma Inc., of Princeton, N.J., named Joel A. Tune to its board...PharmAthene Inc., of Annapolis, Md., appointed Charles A. Reinhart III senior vice president and chief financial officer

Laureate Pharma Inc., of Princeton, N.J., appointed Daniel E. Leone vice president of business development...Third Rock Ventures LLC, of Boston, appointed Philip R. Reilly and Gregory L. Verdine venture partners, and Craig M. Greaves recruiting partner

aTyr Pharma Inc., of San Diego, named Bruce Beutler to its scientific advisory board...Nuon Therapeutics Inc., of San Mateo, Calif., appointed Paulette Dillon chief business officer and Tito Serafini chief scientific officer

EUSA Pharma Inc., of Doylestown, Pa., appointed David Cook chief financial officer...Micromet Inc., of Bethesda, Md., named Walter Bodmer and Bernard Fox to its BiTE antibody advisory panel